| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 88.178 | 91.658 | 92.105 | 95.658 | 94.934 | 115.466 | 139.640 | 133.409 | 131.321 | 149.900 |
| Total Income - EUR | 92.090 | 94.563 | 94.484 | 96.160 | 94.934 | 115.466 | 139.766 | 135.592 | 136.216 | 155.620 |
| Total Expenses - EUR | 88.122 | 89.678 | 95.559 | 107.282 | 90.922 | 109.821 | 133.918 | 132.888 | 132.343 | 154.251 |
| Gross Profit/Loss - EUR | 3.968 | 4.885 | -1.076 | -11.122 | 4.012 | 5.645 | 5.848 | 2.703 | 3.873 | 1.369 |
| Net Profit/Loss - EUR | 3.333 | 4.001 | -2.021 | -12.039 | 3.189 | 4.521 | 4.571 | 1.431 | 2.579 | 612 |
| Employees | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - Lavimar Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 653 | 312 | 310 |
| Current Assets | 40.436 | 19.000 | 28.655 | 24.246 | 25.708 | 45.120 | 32.066 | 37.085 | 36.391 | 29.160 |
| Inventories | 28.892 | 8.084 | 11.566 | 3.408 | 6.531 | 14.082 | 3.198 | 5.935 | 11.393 | 8.027 |
| Receivables | 5.745 | 5.032 | 15.410 | 20.029 | 17.218 | 28.276 | 25.601 | 27.734 | 22.063 | 15.028 |
| Cash | 5.798 | 5.884 | 1.679 | 809 | 1.960 | 2.762 | 3.267 | 3.416 | 2.934 | 6.105 |
| Shareholders Funds | 5.197 | 9.145 | 6.970 | -5.197 | -1.907 | 2.651 | 7.163 | 8.616 | 11.169 | 11.718 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.238 | 9.855 | 21.686 | 29.443 | 27.615 | 42.469 | 24.903 | 29.122 | 25.533 | 17.752 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Lavimar Med Srl